Physician profile
Fadi Abbass
NPI 1639283914
$2,318.90
in general payments reported to CMS, 2019-2025
13 companies · $71.26 in 2025
The $71.26 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $50.37 · 2021: $209 · 2022: $154 · 2023: $1,438 · 2024: $261 · 2025: $71.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,153 · Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,152.78 |
| Food and Beverage | $618.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,475.02 | 2023-2024 | Inspire |
| Aerin Medical INC. | $147.29 | 2021-2025 | |
| Cochlear Americas | $105.75 | 2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Optinose US, INC. | $97.88 | 2019-2024 | |
| 3-D Matrix, INC. | $96.83 | 2022 | |
| Stryker Corporation | $91.16 | 2019-2025 | Audion Et Dilation System |
| Acclarent, INC | $80.66 | 2021-2023 | Acclarent Balloon Inflation Device |
| Phadia US INC. | $61.78 | 2022-2023 | Immunocap |
| Intersect Ent, INC. | $40.34 | 2019 | |
| Ethicon US, LLC | $40.27 | 2022-2025 | Ethicon |
| Merck Sharp & Dohme LLC | $37.96 | 2023 | |
| Glaxosmithkline, LLC. | $30.43 | 2021-2025 | Nucala |
| Kerecis Limited | $13.53 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Abbass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.